4245 related articles for article (PubMed ID: 3806589)
21. Antineoplastic activity of azacarbazoles. I. Synthesis and antitumor properties of alpha-carboline and its selected derivatives.
Wieczorek J; Peczyńska-Czoch W; Mordarski M; Kaczmarek L; Nantka-Namirski P
Arch Immunol Ther Exp (Warsz); 1986; 34(3):315-21. PubMed ID: 3592935
[TBL] [Abstract][Full Text] [Related]
22. Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro.
Szmigielska-Kaplon A; Ciesielska E; Szmigiero L; Robak T
Eur J Haematol; 2002 Jun; 68(6):370-5. PubMed ID: 12225395
[TBL] [Abstract][Full Text] [Related]
23. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
[TBL] [Abstract][Full Text] [Related]
24. In the search for new anticancer drugs, XXI. Spin labeled nitrosoureas.
Sosnovsky G; Li SW; Rao NU
Z Naturforsch C J Biosci; 1987; 42(7-8):921-31. PubMed ID: 2961152
[TBL] [Abstract][Full Text] [Related]
25. New antitumor agents containing the anthracene nucleus.
Wunz TP; Dorr RT; Alberts DS; Tunget CL; Einspahr J; Milton S; Remers WA
J Med Chem; 1987 Aug; 30(8):1313-21. PubMed ID: 2441053
[TBL] [Abstract][Full Text] [Related]
26. Development of mitoxantrone.
White RJ; Durr FE
Invest New Drugs; 1985; 3(2):85-93. PubMed ID: 2410393
[TBL] [Abstract][Full Text] [Related]
27. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
Klohs WD; Steinkampf RW; Havlick MJ; Jackson RC
Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of 2-fluoro-8-azaadenosine and related compounds.
Montgomery JA; Shortnacy AT; Secrist JA
J Med Chem; 1983 Oct; 26(10):1483-9. PubMed ID: 6620307
[TBL] [Abstract][Full Text] [Related]
29. New designs in inorganic ring systems as anticancer drugs. Antitumor activity of the aziridino (ethylene-imino) derivatives (NPAz2)2NSOX with X = F, Az, Ph.
Labarre JF; Sournies F; Cros S; François G; van de Grampel JC; van der Huizen AA
Cancer Lett; 1981 Apr; 12(3):245-50. PubMed ID: 7260894
[No Abstract] [Full Text] [Related]
30. In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles).
Fry DW; Boritzki TJ; Besserer JA; Jackson RC
Biochem Pharmacol; 1985 Oct; 34(19):3499-508. PubMed ID: 2413861
[TBL] [Abstract][Full Text] [Related]
31. 3'-Hydroxyesorubicin. Synthesis and antitumor activity.
Priebe W; Neamati N; Perez-Soler R
J Antibiot (Tokyo); 1990 Jul; 43(7):838-46. PubMed ID: 2387778
[TBL] [Abstract][Full Text] [Related]
32. Overadditive synergism between the intercalators mitoxantrone and lucanthone in advanced L 12010 and P 388 leukemia.
Osswald H; Youssef M
J Cancer Res Clin Oncol; 1986; 111(2):137-40. PubMed ID: 2939092
[TBL] [Abstract][Full Text] [Related]
33. Effect of 3'-amino-3'-deoxythymidine on L1210 and P388 leukemias in mice.
Lin TS; Fischer PH; Prusoff WH
Biochem Pharmacol; 1982 Jan; 31(1):125-8. PubMed ID: 7059345
[No Abstract] [Full Text] [Related]
34. Antitumour activity of some cyclophosphazenes.
Labarre JF; Faucher JP; Levy G; Sournies F; Cros S; François G
Eur J Cancer (1965); 1979 May; 15(5):637-43. PubMed ID: 510331
[No Abstract] [Full Text] [Related]
35. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of 2,7-Dihydro-3H-dibenzo[de,h]cinnoline-3,7-dione derivatives, a novel group of anticancer agents active on a multidrug resistant cell line.
Stefańska B; Arciemiuk M; Bontemps-Gracz MM; Dzieduszycka M; Kupiec A; Martelli S; Borowski E
Bioorg Med Chem; 2003 Feb; 11(4):561-72. PubMed ID: 12538021
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
Chiuten DF; Muggia FM; Johnson RK
Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512
[No Abstract] [Full Text] [Related]
38. Potential antitumor agents. 38. 3-substituted 5-carboxamido derivatives of amsacrine.
Denny WA; Atwell GJ; Baguley BC
J Med Chem; 1983 Nov; 26(11):1619-25. PubMed ID: 6688829
[TBL] [Abstract][Full Text] [Related]
39. In vivo and in vitro effectivity of some platinum complexes.
Balázová E; Hrubisko M; Ujházy V
Neoplasma; 1984; 31(6):641-7. PubMed ID: 6395026
[TBL] [Abstract][Full Text] [Related]
40. [The synthesis and biologic activity of analogs of 1,4-benzoquinone-guanylhydrazone-thiosemicarbazone. 2. Substitution at the quinone ring by alkyl groups].
Schulze W; Gutsche W; Wohlrabe K; Tresselt D; Horn G; Fleck W
Pharmazie; 1986 Feb; 41(2):99-101. PubMed ID: 3725863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
